Back to Top
Antibody Drug Conjugate
-
Labetuzumab Govitecan Biosimilar - Research Grade$700.00 - $3,024.00 -
Ladiratuzumab Vedotin Biosimilar - Research Grade$700.00 - $3,024.00
-
Laprituximab Emtansine Biosimilar - Research Grade$1,050.00 - $4,536.00
-
-
-
Praluzatamab Ravtansine Biosimilar - Research Grade$1,050.00 - $4,536.00
-
Praluzatamab Vedotin Biosimilar - Research Grade$700.00 - $3,024.00
-
-
Talacotuzumab Vedotin Biosimilar - Research Grade$700.00 - $3,024.00
-
-
Vorsetuzumab Mafodotin Biosimilar - Research Grade$700.00 - $3,024.00
Who Bought This Also Bought
